Case Comprehensive Cancer Center

Collaboration across Case Western Reserve University, Cleveland Clinic and University Hospitals continues at one of nation's elite cancer centers The Case Comprehensive Cancer Center, Northeast Ohio's coordinated effort to combat cancer, has earned an additional $12 million from the National…

Collaboration across Case Western Reserve University, Cleveland Clinic and University Hospitals continues at one of nation's elite cancer centers CLEVELAND—The Case Comprehensive Cancer Center, Northeast Ohio's coordinated effort to combat cancer, has earned an additional $12 million from the…

We wish sincere congratulations to Cancer Center director Stan Gerson on his appointment as dean of the Case Western Reserve University School of Medicine effective October 1, 2021 following a national search. The announcement was made today by President Eric Kaler and Provost Ben Vinson III, who…

President Eric W. Kaler and Provost Ben Vinson III announced today that they have named Stan Gerson as the medical school’s dean and the university’s senior vice president for medical affairs. His appointment begins Oct. 1. “We are delighted that Stan will continue to provide the exceptional…

Agreement Offers Additional Collaboration Opportunities between Organizations and across Northeast Ohio CLEVELAND, February 1, 2021 —Case Western Reserve University (CWRU) and University Hospitals (UH) have extended their affiliation through 2031 in an amendment that expands opportunities for…

The Cancer Center Seminar Series will kick off Friday, Sept. 10, at noon in Wolstein Research Building Auditorium (1-413). Partha Roy, associate professor of bioengineering and pathology at the University of Pittsburgh, will present “Targeting actin-regulatory protein in clear cell renal…

NCI-designated cancer centers, AACI members and other cancer centers and medical groups endorse HPV vaccination and cancer screening to eliminate cancers caused by the virus. The Case Comprehensive Cancer Center - a partnership of Case Western Reserve University, Cleveland Clinic and University…

Jianjun Zhao, MD, PhD, has received a five-year, nearly $2.6 million grant from the National Cancer Institute, part of the National Institutes of Health, to investigate a new approach for treating chemotherapy-associated kidney damage. In study results published last year, Dr. Zhao and his team…

The Affordable Cancer Technology (ACT 2021) Conference is a global oncology virtual event open to the public for the first time Sept. 23–24. The focus will be the intersection of technological innovation, cancer research, and global disparities, and it will bring together researchers, public health…

The U.S. Patent and Trademark Office has issued the first U.S. patent for a novel ovarian cancer vaccine technology developed by Cleveland Clinic researchers Vincent K. Tuohy, PhD, Suparna Mazumder, PhD, and Justin M. Johnson. The technology is licensed worldwide by Anixa Biosciences, Inc., a…